Large molecules

Two scientists working in a lab
#Antibody discovery workflow #Biotherapeutics #Cell line development #Cell lines #Drug development #Large molecules

Advancements in upstream CLD for enhanced biotherapeutics production

This article is sponsored by Revvity. By Anis H Khimani, PhD, Senior Strategy Leader, Life Sciences strategy group, Revvity, Inc. Across the biotherapeutics workflow The landscape of large molecule drug development has evolved significantly in recent decades. As the significance of large molecules… Read More

#Exclusive Content